# PRAVASTATIN SODIUM

NDC: 0615-8540
Generic name: PRAVASTATIN SODIUM
Labeler / Manufacturer: NCS HealthCare of KY, LLC dba Vangard Labs
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20240601
Marketing ended: 20261130
FDA application: ANDA077987

## Active ingredients

- PRAVASTATIN SODIUM: 20 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0615-8540"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0615-8540
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=27ba8a69-b5aa-40eb-89f7-6bf2c1fcceae